These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9813483)

  • 21. The haemolytic effect of various regimens of primaquine with chloroquine in American Negroes with G6PD deficiency and the lack of an effect of various antimalarial suppressive agents on erythrocyte metabolism.
    Brewer GJ; Zarafonetis CJ
    Bull World Health Organ; 1967; 36(2):303-8. PubMed ID: 4864652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methemoglobinemia and adverse events in Plasmodium vivax malaria patients associated with high doses of primaquine treatment.
    Carmona-Fonseca J; Alvarez G; Maestre A
    Am J Trop Med Hyg; 2009 Feb; 80(2):188-93. PubMed ID: 19190211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reinventing primaquine for endemic malaria.
    Baird JK
    Expert Opin Emerg Drugs; 2012 Dec; 17(4):439-44. PubMed ID: 22998791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucose-6-phosphate dehydrogenase deficiency and antimalarial drug development.
    Beutler E; Duparc S;
    Am J Trop Med Hyg; 2007 Oct; 77(4):779-89. PubMed ID: 17978087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Malaria chemoprophylaxis in the age of drug resistance. II. Drugs that may be available in the future.
    Shanks GD; Kain KC; Keystone JS
    Clin Infect Dis; 2001 Aug; 33(3):381-5. PubMed ID: 11438908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primaquine as prophylaxis for malaria for nonimmune travelers: A comparison with mefloquine and doxycycline.
    Schwartz E; Regev-Yochay G
    Clin Infect Dis; 1999 Dec; 29(6):1502-6. PubMed ID: 10585803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [New use of primaquine for malaria].
    Oliver M; Simon F; de Monbrison F; Beavogui AH; Pradines B; Ragot C; Moalic JL; Rapp C; Picot S
    Med Mal Infect; 2008 Apr; 38(4):169-79. PubMed ID: 18395381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Manifestation of glucose-6-phosphate dehydrogenase deficiency caused by primaquine in malaria therapy].
    Blümel P; Stögmann W
    Padiatr Padol; 1983; 18(3):313-7. PubMed ID: 6350992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implications.
    Luzzatto L; Seneca E
    Br J Haematol; 2014 Feb; 164(4):469-80. PubMed ID: 24372186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A case of acute drug-induced hemolytic anemia associated with glucoso-6-phosphate dehydrogenase deficiency].
    Dul'tsina SM; Matveev MP; Shatunova LV
    Vopr Okhr Materin Det; 1967 Feb; 12(2):81-4. PubMed ID: 5611382
    [No Abstract]   [Full Text] [Related]  

  • 31. Problems in the therapy for imported malaria in the United States.
    Singh K; Wester WC; Trenholme GM
    Arch Intern Med; 2003 Sep; 163(17):2027-30. PubMed ID: 14504115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of malaria among French adult travellers.
    Malvy D; Pistone T; Rezvani A; Lançon F; Vatan R; Receveur MC; Durand I; Hercberg S; El Hasnaoui A
    Travel Med Infect Dis; 2006 Sep; 4(5):259-69. PubMed ID: 16905456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haemolytic potential of three chemotherapeutic agents and aspirin in glucose-6-phosphate dehydrogenase deficiency.
    Ali NA; al-Naama LM; Khalid LO
    East Mediterr Health J; 1999 May; 5(3):457-64. PubMed ID: 10793824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Haemolytic crisis in a Zanzibari Arab girl with G6PD deficiency and sickle cell trait.
    Chopra SA
    East Afr Med J; 1968 Nov; 45(11):726-7. PubMed ID: 5721119
    [No Abstract]   [Full Text] [Related]  

  • 35. Malaria prevention in travelers.
    Juckett G
    Am Fam Physician; 1999 May; 59(9):2523-30, 2535-6. PubMed ID: 10323359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical laboratory indices of hemolysis in persons with various types of haptoglobin in preventive primaquine therapy of malaria].
    Shcherbakov AM; Ozeretskovskaia NN; Bronshteĭn AM; Benediktov II; Lachinova RI
    Med Parazitol (Mosk); 1975; 44(3):288-92. PubMed ID: 1177820
    [No Abstract]   [Full Text] [Related]  

  • 37. Rapid epidemiologic assessment of glucose-6-phosphate dehydrogenase deficiency in malaria-endemic areas in Southeast Asia using a novel diagnostic kit.
    Jalloh A; Tantular IS; Pusarawati S; Kawilarang AP; Kerong H; Lin K; Ferreira MU; Matsuoka H; Arai M; Kita K; Kawamoto F
    Trop Med Int Health; 2004 May; 9(5):615-23. PubMed ID: 15117307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malaria prevention and stand-by emergency treatment among Japanese travelers.
    Kimura M; Kawakami K; Hashimoto M; Hamada M
    Travel Med Infect Dis; 2006 Mar; 4(2):81-5. PubMed ID: 16887729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primaquine prophylaxis against malaria.
    Heppner DG; Gasser RA; Kester KE
    Ann Intern Med; 1999 Mar; 130(6):536; author reply 536-7. PubMed ID: 10075625
    [No Abstract]   [Full Text] [Related]  

  • 40. Simultaneous drug reactions in the same patient. Chloroquine-Primaquine sensitivity.
    Stevenson DD; McGerity JL
    JAMA; 1970 Apr; 212(4):624-6. PubMed ID: 5467364
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.